Related Experiment Video
Updated: Apr 29, 2026

09:37
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.5K
Gene therapy in endocrine tumors: a comprehensive overview
Padmanaban S Suresh1, Thejaswini Venkatesh, Rie Tsutsumi
1Centre for Biomedical Research, VIT University, Vellore-632014, India.
Endocrine Journal
|May 16, 2014
Summary
Developing new gene therapies is crucial for endocrine cancers due to current treatment limitations. This review summarizes gene therapy research, highlighting progress and challenges for effective endocrine cancer management.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Current treatments for endocrine cancers have significant limitations.
- There is a pressing need for novel and effective therapeutic strategies.
- Gene therapy offers a potential therapeutic option for endocrine cancers.
Purpose of the Study:
- To summarize existing gene therapy interventions for endocrine cancers.
- To highlight recent progress and major limitations in endocrine cancer gene therapy.
- To provide a comprehensive overview of gene therapy studies in endocrine cancers.
Main Methods:
- Systematic literature review of gene therapy studies in endocrine cancers.
- Evaluation of translational investigations stemming from successful studies.
- Analysis of limitations and advancements in the field.
Main Results:
- A comprehensive overview of diverse gene therapy approaches evaluated in endocrine cancers.
- Identification of successful studies progressing to translational research.
- Recognition of significant challenges and limitations in current gene therapy applications.
Conclusions:
- Gene therapy research shows promise for endocrine cancers.
- Translational investigations are emerging from preclinical studies.
- An integrative approach is necessary to overcome gene therapy challenges in endocrine cancers.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies
1.4K
1.4K
Gene Therapy
22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Gene Therapy
4.5K
4.5K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

